Open this publication in new window or tab >>Show others...
2022 (English)In: Brain, ISSN 0006-8950, E-ISSN 1460-2156, Vol. 1145, no 10, p. 3637-3653Article in journal (Refereed) Published
Abstract [en]
Middleton, Perini et al. show that the role of Na(v)1.7 extends beyond pain perception. Using a multidisciplinary, cross-species approach, they show that Na(v)1.7 is also essential for C-low threshold mechanoreceptor function in mice and humans, regulating pleasant touch, punctate discrimination and sensitivity to cooling. Patients with bi-allelic loss of function mutations in the voltage-gated sodium channel Nav1.7 present with congenital insensitivity to pain (CIP), whilst low threshold mechanosensation is reportedly normal. Using psychophysics (n = 6 CIP participants and n = 86 healthy controls) and facial electromyography (n = 3 CIP participants and n = 8 healthy controls), we found that these patients also have abnormalities in the encoding of affective touch, which is mediated by the specialized afferents C-low threshold mechanoreceptors (C-LTMRs). In the mouse, we found that C-LTMRs express high levels of Nav1.7. Genetic loss or selective pharmacological inhibition of Nav1.7 in C-LTMRs resulted in a significant reduction in the total sodium current density, an increased mechanical threshold and reduced sensitivity to non-noxious cooling. The behavioural consequence of loss of Nav1.7 in C-LTMRs in mice was an elevation in the von Frey mechanical threshold and less sensitivity to cooling on a thermal gradient. Nav1.7 is therefore not only essential for normal pain perception but also for normal C-LTMR function, cool sensitivity and affective touch.
Place, publisher, year, edition, pages
OXFORD UNIV PRESS, 2022
Keywords
affective touch; C-low threshold mechanoreceptors; congenital insensitivity to pain; Na(v)1; 7
National Category
Clinical Laboratory Medicine
Identifiers
urn:nbn:se:liu:diva-187747 (URN)10.1093/brain/awab482 (DOI)000839656800001 ()34957475 (PubMedID)
Note
Funding Agencies|Wellcome Trust [102645/Z/13/Z]; UK Medical Research Council [MR/T020113/1]; NIHR Cambridge Clinical Research Facility; NIHR Eastern Clinical Research; Swedish Research Council [2015-02684]; ALF Grants; Region Ostergotland; Knut and Alice Wallenberg Foundation; Wellcome [202747/Z/16/Z]
2022-08-302022-08-302023-02-16Bibliographically approved